Randomized Phase III Trial to Test Accelerated Versus Standard Fractionation in Combination With Concurrent Cisplatin for Head and Neck Carcinomas in the Radiation Therapy Oncology Group 0129 Trial: Long-Term Report of Efficacy and Toxicity

PURPOSE: We tested the efficacy and toxicity of cisplatin plus accelerated fractionation with a concomitant boost (AFX-C) versus standard fractionation (SFX) in locally advanced head and neck carcinoma (LA-HNC). PATIENTS AND METHODS: Patients had stage III to IV carcinoma of the oral cavity, orophar...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:J Clin Oncol
Glavni autori: Nguyen-Tan, Phuc Felix, Zhang, Qiang, Ang, K. Kian, Weber, Randal S., Rosenthal, David I., Soulieres, Denis, Kim, Harold, Silverman, Craig, Raben, Adam, Galloway, Thomas J., Fortin, André, Gore, Elizabeth, Westra, William H., Chung, Christine H., Jordan, Richard C., Gillison, Maura L., List, Marcie, Le, Quynh-Thu
Format: Artigo
Jezik:Inglês
Izdano: American Society of Clinical Oncology 2014
Teme:
ORIGINAL REPORTS
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4239304/
https://ncbi.nlm.nih.gov/pubmed/25366680
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2014.55.3925
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items